Mitralign is a venture-backed, valve repair company located near Boston, Massachusetts, U.S.A. that is developing an innovative therapy to address life-threatening cardiac valve conditions affecting more than 5 million patients in the U.S.A. alone.
Mitralign is the only company to provide a direct transcatheter annuloplasty system, designed to treat both functional mitral regurgitation (“FMR”) and functional tricuspid regurgitation (“FTR”), both diseases that occur when the mitral or tricuspid valve fails to open and close properly, causing blood to flow backwards into the upper chamber of the heart. If left untreated, FMR and FTR can lead to heart enlargement and heart failure. The first application of this innovation, the Mitralign Percutaneous Annuloplasty System (MPAS) for FMR, earned CE mark in early 2016. The Trialign System for FTR is being investigated in an early feasibility study in the U.S.A.
1. Rick Geoffrion (President & CEO)
Mr. Geoffrion currently serves as the President and Chief Executive Officer of Mitralign, a venture-backed private company that has developed a transcatheter platform for mitral and tricuspid valve repair. Rick has over 30 years of management experience in the medical device industry and more than 25 years in the cardiovascular device space.
A co-founder of Mitralign, he previously led the company foundation and served as the early stage CEO for three additional medical device companies (CircuLite, FlowMedica, X-Cell). He also guided the recapitalisation and redirection of two successful medical device companies (Impella, Pathway).
Mr. Geoffrion served as the Chairman of Impella CardioSystems AG, CircuLite and FlowMedica, Inc. He holds a BSME and an MBA from the University of Connecticut.
2. Lisa Wipperman Heine (Chief Operating Officer)
Ms Heine brings 25 years of medical device experience to Mitralign. Prior to joining Mitralign, Lisa was most recently Founder and Principal at deArca Strategic Solutions, LLC, a provider of medical device strategic consulting.
Prior to deArca, Lisa was Global Vice President of Medical Affairs at Covidien in the Vascular Therapies Business Unit where she was responsible for the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Professionals Affairs and Clinical Education (PACE). Her additional experience includes operational roles in regulatory affairs as well as sales and marketing.
Lisa is also adjunct faculty in the Applied Clinical Research Graduate Program at St. Cloud State University. She received her bachelor’s degree from St. Olaf College and her graduate degree from the University of Manitoba.
3. Steven Cahalane (Chief Technology Officer)
Mr. Cahalane has spent over 20 years in product development, operations and quality management in the medical device industry. Prior to joining Mitralign, he worked in R&D and Operations management at Percardia, Inc. Before that, he worked in Operations and Quality Assurance management at Boston Scientific as well as quality engineering at C.R. Bard. He has a BS in Plastics Engineering from the University of Lowell.